Division of Molecular and Cellular Medicine, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.
Sci Rep. 2013;3:1197. doi: 10.1038/srep01197. Epub 2013 Feb 1.
Alzheimer's disease (AD) is characterized by the accumulation of β-amyloid peptide (Aβ) in the brain because of an imbalance between Aβ production and clearance. Neprilysin (NEP) is the most important Aβ-degrading enzyme in the brain. Thus, researchers have explored virus-mediated NEP gene delivery. However, such strategies may entail unexpected risks, and thus exploration of a new possibility for NEP delivery is also required. Here, we show that human adipose tissue-derived mesenchymal stem cells (ADSCs) secrete exosomes carrying enzymatically active NEP. The NEP-specific activity level of 1 μg protein from ADSC-derived exosomes was equivalent to that of ~ 0.3 ng of recombinant human NEP. Of note, ADSC-derived exosomes were transferred into N2a cells, and were suggested to decrease both secreted and intracellular Aβ levels in the N2a cells. Importantly, these characteristics were more pronounced in ADSCs than bone marrow-derived mesenchymal stem cells, suggesting the therapeutic relevance of ADSC-derived exosomes for AD.
阿尔茨海默病(AD)的特征是由于 Aβ 产生和清除之间的失衡,β-淀粉样肽(Aβ)在大脑中积累。神经肽酶(NEP)是大脑中最重要的 Aβ 降解酶。因此,研究人员探索了病毒介导的 NEP 基因传递。然而,这种策略可能带来意想不到的风险,因此也需要探索 NEP 传递的新可能性。在这里,我们表明人脂肪组织来源的间充质干细胞(ADSCs)分泌携带具有酶活性的 NEP 的外泌体。从 ADSC 衍生的外泌体中 1μg 蛋白的 NEP 比活性水平相当于约 0.3ng 的重组人 NEP。值得注意的是,ADSC 衍生的外泌体被转染到 N2a 细胞中,并被认为降低了 N2a 细胞中分泌的和细胞内的 Aβ 水平。重要的是,ADSC 衍生的外泌体比骨髓间充质干细胞具有更显著的特征,这表明 ADSC 衍生的外泌体在 AD 中的治疗相关性。